NEDD9 and ovarian carcinoma: NEDD9 is associated with the tumorigenesis of breast cancer20 and ovarian cancer,21 and the upregulation of NEDD9 in HCC is associated with epithelial-mesenchymal transition and intrahepatic metastasis22 and is related to poor patient prognosis.23